SCHEMBL30165634

SCHEMBL30165634

Nc1nc(-c2ccc3[nH]ccc3c2)nc2[nH]ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47
NPC1 O15118 1/20 0.45
MAP3K11 Q16584 4/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
LRRK2 Q5S007 3/20 0.43
CYP2C9 P11712 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
PSMB8 P28062 1/20 0.42
FYN P06241 1/20 0.42
KDM1A O60341 1/20 0.41
NISCH Q9Y2I1 1/20 0.41
PI4K2A Q9BTU6 1/20 0.41
CYP17A1 P05093 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16963640 0.83 ROCK2 (0.49) ADORA2AFYN
SCHEMBL1900222 0.77 CYP1A1 (0.53) ADORA2AADORA1NPC1
SCHEMBL7655542 0.77 CYP17A1 (0.45) ADORA2AADORA1NPC1MAP3K11CYP3A4
SCHEMBL14274543 0.76 ADORA1 (0.51) ADORA2AADORA1LRRK2
SCHEMBL20162678 0.72 PDGFRB (0.45) NPC1CA12CA1CA2CA9
Hydrochloric Acid SCHEMBL7019753 0.71 ABCG2 (0.39) ADORA2AADORA1
SCHEMBL10213928 0.71 JAK2 (0.61) NPC1MAP3K11CYP3A4CYP2D6CA12
SCHEMBL5850255 0.71 NPC1 (0.79) NPC1MAP3K11CA12CA1CA2
SCHEMBL16497095 0.70 NUDT1 (0.43) ADORA2AADORA1LRRK2
SCHEMBL18828552 0.69 NPC1 (0.59) ADORA2AADORA1NPC1MAP3K11CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11547704-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11547704-B2 Chemical compounds ATF4, XBP1, EIF2B5 ADORA2A 2289/4885ADORA1 2202/4885NPC1 119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.